Eddie Baker, 83, participated in a clinical trial named EPIC for penile cancer that combined immunotherapy and chemotherapy. He believes this treatment may have extended his life by two years. The trial showed that over half of its participants experienced an increase in predicted lifespan. Baker faced a late diagnosis due to stigma around symptoms, which can prevent timely medical consultation. Despite the newness of immunotherapy, it shows promise for treatment, although it is not yet available on the NHS.
Eddie Baker, 83, revealed that participation in the EPIC clinical trial for penile cancer, involving immunotherapy and chemotherapy, may have extended his life by two years.
The EPIC trial showed that immunotherapy improved the predicted lifespans of over half of its participants, despite being a relatively new approach.
Consultant oncologist Professor Amit Bahl emphasized the stigma surrounding penile cancer symptoms leads to late diagnoses, limiting support and awareness for affected individuals.
Baker, who faced an amputation due to late-stage cancer, described the trial as the 'most wonderful thing' that allowed him to continue living.
Collection
[
|
...
]